Cleared Traditional

K915163 - PROTEIN S EID KIT AND PROTEIN S EID BULK PLATES

K915163 is an FDA 510(k) clearance for PROTEIN S EID KIT AND PROTEIN S EID BUL..., manufactured by Biopool AB. The device is a Class 2 Hematology device with product code GGP cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K915163 · Biopool AB · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1992
Decision
53d
Days
Class 2
Risk

K915163 is an FDA 510(k) clearance for the PROTEIN S EID KIT AND PROTEIN S EID BULK PLATES. Classified as Test, Qualitative And Quantitative Factor Deficiency (product code GGP), Class II - Special Controls.

Submitted by Biopool AB (Ontario L8r 3k8, CA). The FDA issued a Cleared decision on January 6, 1992 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biopool AB devices

FDA 510(k) Submission Details - K915163

510(k) Number K915163 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 1991
Decision Date January 06, 1992
Days to Decision 53 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 113d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGP Device Classification - Class 2, Special Controls

Product Code GGP Test, Qualitative And Quantitative Factor Deficiency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGP Test, Qualitative And Quantitative Factor Deficiency

All 158
Devices cleared under the same product code (GGP) and FDA review panel - the closest regulatory comparables to K915163.
IL TEST(TM) ALPHA-2-ANTIPLASMIN ASSAY SYSTEM
K920012 · Instrumentation Laboratory CO · Aug 1992
RISTOCETIN COFACTOR ASSAY/VON WILLEBRAND FACT ASSA
K920981 · Medical Diagnostic Technologies, Inc. · Apr 1992
DADE(R) ALPHA 2 ANTIPLASMIN(2 2-AP) CHROMO ASSAY
K914818 · Baxter Diagnostics, Inc. · Jan 1992
IL TEST PROCLOT ASSAY STYSTEM
K912711 · Instrumentation Laboratory CO · Oct 1991
STACLOT(R) PROTEIN S TEST KIT
K913424 · American Bioproducts Co. · Oct 1991
LIATEST PROTEIN S KIT
K912468 · American Bioproducts Co. · Oct 1991